Cellular and Molecular Life Sciences CMLS

, Volume 61, Issue 5, pp 567–579

Interleukin-17: a mediator of inflammatory responses

Authors

    • Department of PathophysiologyUniversity Medical School
    • Department of Nephrology and Medical Intensive CareUniversitätsklinikum Charité
  • K. Książek
    • Department of PathophysiologyUniversity Medical School
  • A. Jörres
    • Department of Nephrology and Medical Intensive CareUniversitätsklinikum Charité
Review

DOI: 10.1007/s00018-003-3228-z

Cite this article as:
Witowski, J., Książek, K. & Jörres, A. CMLS, Cell. Mol. Life Sci. (2004) 61: 567. doi:10.1007/s00018-003-3228-z

Abstract

Interleukin-17 (IL-17) is a prototype member of a new cytokine family with six species identified to date. IL-17 is secreted mainly by activated CD4+ and CD8+ T lymphocytes, while its receptor is distributed ubiquitously. IL-17 has been classified as a proinflammatory cytokine because of its ability to induce the expression of many mediators of inflammation, most strikingly those that are involved in the proliferation, maturation and chemotaxis of neutrophils. Increased levels of IL-17 have been associated with several conditions, including airway inflammation, rheumatoid arthritis, intraperitoneal abscesses and adhesions, inflammatory bowel disease, allograft rejection, psoriasis, cancer and multiple sclerosis. This review provides an overview of IL-17 activities, concentrating on those that lead to neutrophil recruitment.

IL-17T cellsinflammationchemokinesgranulopoiesis
Download to read the full article text

Copyright information

© Birkhäuser-Verlag Basel 2004